Skip to main navigation Skip to search Skip to main content

Therapeutic drug monitoring of nevirapine reduces pharmacokinetic variability but does not affect toxicity or virologic success in the ATHENA study [1]

  • Kristel M. Crommentuyn
  • , Alwin D. Huitema
  • , Kees Brinkman
  • , Marchina E. Van Der Ende
  • , Frank De Wolf
  • , Jos H. Beijnen

Research output: Contribution to journalLetterpeer-review

16 Citations (Scopus)
Original languageEnglish
Pages (from-to)249-250
Number of pages2
JournalJournal of Acquired Immune Deficiency Syndromes
Volume39
Issue number2
Publication statusPublished - 1 Jun 2005
Externally publishedYes

Cite this